加拿大ProMetic Life Sciences Inc.  www.prometic.com
ProMetic Life Sciences Inc. 是一家专注于研发、制造与营销多种源自其专有 Mimetic Ligand(TM) 技术的商业性应用产品的生物制药公司。Mimetic Ligand(TM) 技术被用于大规模的生物制剂净化以及病原体消灭。ProMetic 还积极从事治疗药物的开发，其使命是为市场提供有效、创新、成本更低、毒性更小的产品，用于治疗血液疾病与癌症。该公司的药物发现平台致力于用人工合成的“类似药物的”蛋白质模拟产品来取代复杂昂贵的蛋白质。ProMetic 总部位于加拿大蒙特利尔，在英国、美国和加拿大设有研发机构，在英国设有制造工厂，并在美国、欧洲、亚洲以及中东开展业务开发活动。

ProMetic is a global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission of bringing to market effective, innovative, lower cost products for the treatment of hematological and nephrological disorders and cancer. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the USA and Canada, manufacturing facilities in the UK and business development activities in the USA, Europe, Asia and in the Middle-East. ProMetic focuses its activities in the Protein Technologies and Therapeutics markets.